Lisata Therapeutics (LSTA) Metrics: History & Chart

Lisata Therapeutics, Inc.(LSTA)

Biotechnology · Basking Ridge, NJ

$1.16-0.10 (-7.94%)

Delayed quote: Oct 6, 2026, 1:52 PM EDT

About Lisata Therapeutics, Inc.

Lisata Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on pioneering and bringing to market cellular therapies. These treatments are designed to either reverse disease progression or facilitate the repair of damaged bodily tissues. The company's product portfolio features several notable candidates: HONEDRA, which has received SAKIGAKE designation and is presently in Phase II clinical trials for critical limb ischemia; XOWNA, currently undergoing Phase IIb testing for coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy aimed at individuals with chronic kidney disease who are not yet on dialysis. Founded in 1980 and based in Basking Ridge, New Jersey, the company was initially known as NeoStem, Inc., then rebranded as Caladrius Biosciences, Inc. in June 2015, before assuming its present identity as Lisata Therapeutics, Inc. on September 15, 2022.

Basking Ridge, NJ

21 employees

www.lisata.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: David J. Mazzo

View full financials

Third-Party DCF Estimate (FMP)	$1.91
Price Gap vs Third-Party Estimate	+52.40%

7D Total Return	-15.95%
30D Total Return	-23.63%
YTD Total Return	-32.25%
1Y Total Return	-50.00%
3Y Total Return	-39.97%
5Y Total Return	-92.70%
10Y Total Return	-98.13%
15Y Total Return	-99.88%
20Y Total Return	-99.99%

2026	-32.25%
2025	-37.58%
2024	+9.14%
2023	+7.95%
2022	-79.93%
2021	-41.26%
2020

CAGR TTM	-49.83%
CAGR 3Y	-15.64%
CAGR 5Y	-40.75%
CAGR 10Y	-32.84%
CAGR 15Y	-36.25%
CAGR 20Y	-37.29%

PE Ratio	2.07
PE Ratio Avg TTM	2.09
PE Ratio Avg 3Y	2.09
Current VS TTM Avg	-1.01%
Current VS 3Y Avg	-1.01%
Current VS 5Y Avg	-1.01%

All Metrics

LSTA Valuation Metrics

LSTA Stock Price Metrics

LSTA Dividend Metrics

LSTA Growth Rate Metrics

LSTA Discounted Cash Flow Metrics

LSTA Returns By Period

LSTA Yearly Returns

LSTA Average Annual Returns By Period (CAGR)

LSTA Revenue Metrics

LSTA PE Ratio Metrics

LSTA PS Ratio Metrics

LSTA PB Ratio Metrics

LSTA Price to Free Cash Flow Ratio Metrics

LSTA Debt to Equity Ratio Metrics

LSTA PEG Ratio Metrics

LSTA FCF Yield

LSTA Earnings Yield

LSTA EBITDA Yield

LSTA OCF Yield

LSTA EV/EBIT Ratio Metrics

LSTA EV/EBITDA Ratio Metrics

LSTA EV/Assets Ratio Metrics

LSTA EV/Sales Ratio Metrics

LSTA Current Ratio Metrics

LSTA Quick Ratio Metrics

LSTA ROIC Metrics

LSTA Return on Assets Metrics

LSTA Return on Equity Metrics

LSTA Net Profit Margin Metrics

LSTA Gross Profit Margin Metrics

LSTA Tax Rate Metrics

PS Ratio	114.74
PS Ratio Avg TTM	104.86
PS Ratio Avg 3Y	73.15
Current VS TTM Avg	+9.42%
Current VS 3Y Avg	+56.87%
Current VS 5Y Avg	+56.87%

PB Ratio	1.39
PB Ratio Avg TTM	1.87
PB Ratio Avg 3Y	0.74
Current VS TTM Avg	-25.73%
Current VS 3Y Avg	+89.11%
Current VS 5Y Avg	+144.54%

PFCF Ratio	5.72
PFCF Ratio Avg TTM	5.33
PFCF Ratio Avg 3Y	5.33
Current VS TTM Avg	+7.34%
Current VS 3Y Avg	+7.34%
Current VS 5Y Avg	+7.34%

Debt/Equity Ratio	0.00
Debt/Equity Ratio Avg TTM	0.00
Debt/Equity Ratio Avg 3Y	0.00
Current VS TTM Avg	-100.00%
Current VS 3Y Avg	-100.00%
Current VS 5Y Avg	-100.00%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	17.49%
FCF Yield Avg TTM	28.10%
FCF Yield Avg 3Y	28.10%
Current VS TTM Avg	-37.76%
Current VS 3Y Avg	-37.76%
Current VS 5Y Avg	-37.76%

Earnings Yield	48.25%
Earnings Yield Avg TTM	53.42%
Earnings Yield Avg 3Y	53.42%
Current VS TTM Avg	-9.68%
Current VS 3Y Avg	-9.68%
Current VS 5Y Avg	-9.68%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	0.09
Ev/Assets Ratio Avg TTM	0.84
Ev/Assets Ratio Avg 3Y	0.20
Current VS TTM Avg	-89.26%
Current VS 3Y Avg	-54.65%
Current VS 5Y Avg	-52.57%

Ev/Sales Ratio	10.31
Ev/Sales Ratio Avg TTM	63.85
Ev/Sales Ratio Avg 3Y	37.14
Current VS TTM Avg	-83.85%
Current VS 3Y Avg	-72.24%
Current VS 5Y Avg	-72.24%

Current Ratio	3.69
Current Ratio Avg TTM	4.83
Current Ratio Avg 3Y	6.96
Current VS TTM Avg	-23.74%
Current VS 3Y Avg	-47.05%
Current VS 5Y Avg	-65.33%

Quick Ratio	3.69
Quick Ratio Avg TTM	4.83
Quick Ratio Avg 3Y	6.96
Current VS TTM Avg	-23.74%
Current VS 3Y Avg	-47.05%
Current VS 5Y Avg	-65.33%

ROIC	(204.32%)
ROIC Avg 3Y	(88.38%)
ROIC Avg 5Y	(73.52%)
Current VS 3Y Avg	-131.18%
Current VS 5Y Avg	-177.92%
Current VS 10Y Avg	-205.48%

ROA	(132.59%)
ROA Avg TTM	(22.64%)
ROA Avg 3Y	(14.33%)
Current VS TTM Avg	-485.72%
Current VS 3Y Avg	-825.05%
Current VS 5Y Avg	-1040.66%

ROE	(177.35%)
ROE Avg TTM	(126.73%)
ROE Avg 3Y	(85.92%)
Current VS TTM Avg	-39.94%
Current VS 3Y Avg	-106.42%
Current VS 5Y Avg	-167.56%

Net Profit Margin	(14621.00%)
Net Profit Margin Avg TTM	(1921.94%)
Net Profit Margin Avg 3Y	0.00%
Current VS TTM Avg	-660.74%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Gross Profit Margin	14.12%
Gross Pft Margin Avg TTM	40.00%
Gross Pft Margin Avg 3Y	0.00%
Current VS TTM Avg	-64.70%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Tax Rate	5.48%
Tax Rate Avg 3Y	5.94%
Tax Rate Avg 5Y	14.36%
Current VS 3Y Avg	-7.71%
Current VS 5Y Avg	-61.83%
Current VS 10Y Avg	-58.39%